Cargando…

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia

BACKGROUND. Although the incidence of adenocarcinomas of the gastroesophageal junction (GEJ) is sharply rising in the Western world, there are still some disagreements about the staging and the treatment of this disease. The aim of this retrospective study was to analyse the effectiveness and safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeromen, Ana, Oblak, Irena, Anderluh, Franc, Velenik, Vaneja, Vidmar, Marija Skoblar, Ratoša, Ivica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita, Warsaw 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572890/ https://www.ncbi.nlm.nih.gov/pubmed/23412351 http://dx.doi.org/10.2478/v10019-012-0049-4

Ejemplares similares

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
por: Ratosa, Ivica, et al.
Publicado: (2015)

Definitive Radiochemotherapy in Esophageal Cancer - A Single Institution Experience
por: Anderluh, Franc, et al.
Publicado: (2019)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
por: Perpar, Ana, et al.
Publicado: (2015)

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
por: Oblak, Irena, et al.
Publicado: (2013)

Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
por: Tuta, Mojca, et al.
Publicado: (2019)

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
por: Velenik, Vaneja, et al.
Publicado: (2010)

Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
por: Velenik, Vaneja, et al.
Publicado: (2012)

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
por: Oblak, Irena, et al.
Publicado: (2016)

Long term outcome after combined modality treatment for anal cancer
por: Oblak, Irena, et al.
Publicado: (2012)

Stereotactic radiosurgery for patients with breast cancer brain oligometastases — molecular subtypes and clinical outcomes
por: Ratosa, Ivica, et al.
Publicado: (2021)

Induction Chemotherapy, Chemoradiotherapy and Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer - Long-term Results of Phase II OIGIT-01 Trial
por: Golo, Danijela, et al.
Publicado: (2018)

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
por: Oblak, Irena, et al.
Publicado: (2011)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
por: Velenik, Vaneja, et al.
Publicado: (2011)

Breast Size Impact on Adjuvant Radiotherapy Adverse Effects and Dose Parameters in Treatment Planning
por: Ratosa, Ivica, et al.
Publicado: (2018)

Telemedicine in Radiation Oncology Post–COVID-19 Pandemic: There Is No Turning Back
por: Orazem, Miha, et al.
Publicado: (2020)

Neoadjuvant radiochemotherapy with cisplatin/5-flourouracil or carboplatin/paclitaxel in patients with resectable cancer of the esophagus and the gastroesophageal junction — comparison of postoperative mortality and complications, toxicity, and pathological tumor response
por: Lorenz, Eric, et al.
Publicado: (2023)

The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection
por: Grosek, Jan, et al.
Publicado: (2016)

Breast Size and Dose to Cardiac Substructures in Adjuvant Three-dimensional Conformal Radiotherapy Compared to Tangential Intensity Modulated Radiotherapy
por: Ratosa, Ivica, et al.
Publicado: (2020)

Post-treatment surveillance in colorectal cancer
por: Velenik, Vaneja
Publicado: (2010)

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
por: Lorenzen, Sylvie, et al.
Publicado: (2020)

Preoperative Intensity-modulated Chemoradiation Therapy with Simultaneous Integrated Boost in Rectal Cancer: 2-year Follow-up Results of Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2018)

Glioblastoma in Patients over 70 Years of Age
por: Smrdel, Uros, et al.
Publicado: (2018)

Impact of Perioperative Treatment on Survival of Resectable Gastric Cancer Patients After D2 Lymphadenectomy: A Single European Centre Propensity Score Matching Analysis
por: Jagric, Tomaz, et al.
Publicado: (2019)

Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
por: Duan, Ran, et al.
Publicado: (2021)

Risk factors and patterns of recurrence after curative resection in Gastroesophageal Junction Adenocarcinoma
por: Batool, Sadaf, et al.
Publicado: (2019)

Impact of COVID-19 on Cancer Diagnosis and Management in Slovenia – Preliminary Results
por: Zadnik, Vesna, et al.
Publicado: (2020)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Gastroesophageal junction adenocarcinoma metastasizing to gingiva
por: Masamatti, Smita S, et al.
Publicado: (2013)

Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
por: Kim, Jin-Jo
Publicado: (2018)

Newborn Screening in Slovenia
por: ŠMON, Andraž, et al.
Publicado: (2015)

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers
por: Kastelowitz, Noah, et al.
Publicado: (2021)

Prognostic Nomogram for Postoperative Patients With Gastroesophageal Junction Cancer of No Distant Metastasis
por: Guo, Qiang, et al.
Publicado: (2021)

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers
por: Skoblar Vidmar, Marija, et al.
Publicado: (2022)

Laparoscopic insertion of pelvic tissue expander prior radiotherapy for sacral metastasis of alveolar maxillary rhabdomyosarcoma to prevent radiation enteritis
por: Omejc, Andrej, et al.
Publicado: (2021)

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
por: Lago, Nieves Martínez, et al.
Publicado: (2020)

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
por: Tian, Yuan, et al.
Publicado: (2021)

Transthoracic Resection versus Non-Transthoracic Resection for Gastroesophageal Junction Cancer: A Meta-Analysis
por: Yang, Kun, et al.
Publicado: (2012)

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma
por: Hirata, Yuki, et al.
Publicado: (2023)

Giant leiomyoma of the gastroesophageal junction: technique and results of endoscopic full-thickness resection
por: Bona, Davide, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6mrn7r8470jsuf834ahr6m9hsj